| Original language | English (US) |
|---|---|
| Pages (from-to) | 841-842 |
| Number of pages | 2 |
| Journal | The Lancet Oncology |
| Volume | 10 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 2009 |
| Externally published | Yes |
Fingerprint
Mass Screening
Vaginal Smears
Cervical Intraepithelial Neoplasia
Papillomavirus Infections
Early Detection of Cancer
Uterine Cervical Neoplasms
Sensitivity and Specificity
ASJC Scopus subject areas
- Oncology
Cite this
Sasieni, P., Castle, P. E., & Cuzick, J. (2009). Further analysis of the ARTISTIC trial. The Lancet Oncology, 10(9), 841-842. https://doi.org/10.1016/S1470-2045(09)70246-3
Further analysis of the ARTISTIC trial. / Sasieni, Peter; Castle, Philip E.; Cuzick, Jack.
In: The Lancet Oncology, Vol. 10, No. 9, 09.2009, p. 841-842.Research output: Contribution to journal › Letter
Sasieni, P, Castle, PE & Cuzick, J 2009, 'Further analysis of the ARTISTIC trial', The Lancet Oncology, vol. 10, no. 9, pp. 841-842. https://doi.org/10.1016/S1470-2045(09)70246-3
Sasieni P, Castle PE, Cuzick J. Further analysis of the ARTISTIC trial. The Lancet Oncology. 2009 Sep;10(9):841-842. https://doi.org/10.1016/S1470-2045(09)70246-3
@article{f81ba30c0f7244ab9744798f96ec1f00,
title = "Further analysis of the ARTISTIC trial",
author = "Peter Sasieni and Castle, {Philip E.} and Jack Cuzick",
year = "2009",
month = "9",
doi = "10.1016/S1470-2045(09)70246-3",
language = "English (US)",
volume = "10",
pages = "841--842",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "9",
}
TY - JOUR
T1 - Further analysis of the ARTISTIC trial
AU - Sasieni, Peter
AU - Castle, Philip E.
AU - Cuzick, Jack
PY - 2009/9
Y1 - 2009/9
UR - http://www.scopus.com/inward/record.url?scp=69149095476&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=69149095476&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(09)70246-3
DO - 10.1016/S1470-2045(09)70246-3
M3 - Letter
C2 - 19717086
AN - SCOPUS:69149095476
VL - 10
SP - 841
EP - 842
JO - The Lancet Oncology
JF - The Lancet Oncology
SN - 1470-2045
IS - 9
ER -